players in the benign prostatic

Benign Prostatic Hyperplasia Treatment Market would record a value tantamount to US$ 12 Bn by 2027.

2022-07-20 // 0 Comments

An exhaustive study published by Fact.MR finds that, transurethral resection of prostate (TURP) surgery is expected to contribute around 30% of market share by 2027, [read full press release…]

Benign Prostatic Hyperplasia Treatment Market worth $14.1 billion by 2026

2022-03-18 // 0 Comments

The study on the benign prostatic hyperplasia (BPH) treatment market is an exclusive report published by Fact.MR, which brings to the fore crucial parameters that [read full press release…]

Benign Prostatic Hyperplasia Treatment Market worth $14.1 billion by 2026

2022-03-18 // 0 Comments

The study on the benign prostatic hyperplasia (BPH) treatment market is an exclusive report published by Fact.MR, which brings to the fore crucial parameters that [read full press release…]